Skip to main content

Advertisement

SpringerLink
Log in

What is the Best Colonoscopy Surveillance for Lynch Syndrome Patients?

  • Prevention and Early Detection (R Benamouzig, Section Editor)
  • Published:
Current Colorectal Cancer Reports

Abstract

Lynch syndrome is the most common form of hereditary colorectal cancer. Screening programs have reduced colon cancer mortality. Despite intensive surveillance, the cumulative risk of developing colorectal cancer is substantial. Identification of modifiable factors has the potential to improve outcome of surveillance. Our article will review current guidelines for Lynch syndrome and how to perform colonoscopy. High-quality surveillance colonoscopy should be performed in an experimented center every 1–2 years, starting at the age of 20–25 years. Colonoscopy should include meticulous inspection and precise removal of all polyps, with special attention to the right colon especially of flat lesions. News endoscopic techniques, such as chromoendoscopy, were developed and recommended to improve the detection of adenomas, particularly of flat adenomas, and minimize the risk of developing interval cancer. Finally, educational intervention in a surveillance program is essential for optimizing screening including adherence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009;76:1–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829–34.

    Article  PubMed  Google Scholar 

  3. Edelstein DL, Axilbund J, Baxter M, Hylind LM, Romans K, Griffin CA, et al. Rapid development of colorectal neoplasia in patients with Lynch syndrome. Clin Gastroenterol Hepatol. 2011;9:340–3.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Plaschke J, Engel C, Krüger S, Holinski-Feder E, Pagenstecher C, Mangold E, et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol. 2004;22:4486–94.

    Article  CAS  PubMed  Google Scholar 

  5. Jass JR, Walsh MD, Barker M, Simms LA, Young J, Leggett BA. Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur J Cancer. 2002;38:858–66.

    Article  CAS  PubMed  Google Scholar 

  6. Rondagh EJA, Gulikers S, Gómez-García EB, Vanlingen Y, Detisch Y, Winkens B, et al. Nonpolypoid colorectal neoplasms: a challenge in endoscopic surveillance of patients with Lynch syndrome. Endoscopy. 2013;45:257–64. In patients with Lynch syndrome, colorectal neoplasms are more likely to have a nonpolypoid shape especially in the proximal colon.

    Article  CAS  PubMed  Google Scholar 

  7. de Jong AE, Morreau H, Van Puijenbroek M, Eilers PH, Wijnen J, Nagengast FM, et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology. 2004;126:42–8.

    Article  PubMed  Google Scholar 

  8. Mecklin J-P, Aarnio M, Läärä E, Kairaluoma MV, Pylvänäinen K, Peltomäki P, et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology. 2007;133:1093–8.

    Article  PubMed  Google Scholar 

  9. Winkels RM, Botma A, Van Duijnhoven FJB, Nagengast FM, Kleibeuker JH, Vasen HFA, et al. Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome. Gastroenterology. 2012;142:241–7.

    Article  PubMed  Google Scholar 

  10. Botma A, Nagengast FM, Braem MGM, Hendriks JCM, Kleibeuker JH, Vasen HFA, et al. Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. J Clin Oncol. 2010;28:4346–53.

    Article  PubMed  Google Scholar 

  11. Vasen HFA, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013;62:812–23. Recommendations by a group of European experts from 13 countries for the appropriate management of families with Lynch Syndrome.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223–62; quiz 263. Recommendations of the American College of Gastroenterology on the diagnosis and management of Lynch syndrome.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kamiński MF, Hassan C, Bisschops R, Pohl J, Pellisé M, Dekker E, et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2014;46:435–49. ESGE recommends the routine use of high definition systems and pancolonic conventional or virtual chromoendoscopy in patients with known or suspected Lynch syndrome.

    Article  PubMed  Google Scholar 

  14. Rubenstein JH, Enns R, Heidelbaugh J, Barkun A. Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome. Gastroenterology. 2015;149:777–82; quiz e16–7.

    Article  PubMed  Google Scholar 

  15. de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, Menko FH, Taal BG, Kleibeuker JH, et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum. 2002;45:1588–94.

    Article  PubMed  Google Scholar 

  16. Box JC, Rodriguez-Bigas MA, Weber TK, Petrelli NJ. Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum. 1999;42:717–21.

    Article  CAS  PubMed  Google Scholar 

  17. Vasen HFA, Abdirahman M, Brohet R, Langers AMJ, Kleibeuker JH, van Kouwen M, et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology. 2010;138:2300–6.

    Article  PubMed  Google Scholar 

  18. Haanstra JF, Vasen HFA, Sanduleanu S, van der Wouden EJ, Koornstra JJ, Kleibeuker JH, et al. Quality colonoscopy and risk of interval cancer in Lynch syndrome. Int J Colorectal Dis. 2013;28:1643–9. Analysis risk of interval cancer on 2,200 medical reports from Lynch syndrome patients.

    Article  CAS  PubMed  Google Scholar 

  19. Engel C, Rahner N, Schulmann K, Holinski-Feder E, Goecke TO, Schackert HK, et al. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol. 2010;8:174–82.

    Article  PubMed  Google Scholar 

  20. Stuckless S, Green JS, Morgenstern M, Kennedy C, Green RC, Woods MO, et al. Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation. Clin Genet. 2012;82:439–45.

    Article  CAS  PubMed  Google Scholar 

  21. de Jong AE, Nagengast FM, Kleibeuker JH, van de Meeberg PC, van Wijk HJ, Cats A, et al. What is the appropriate screening protocol in Lynch syndrome? Fam Cancer. 2006;5:373–8.

    Article  PubMed  Google Scholar 

  22. Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010;102:193–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology. 2008;135:419–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bonadona V, Bonaïti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305:2304–10.

    Article  CAS  PubMed  Google Scholar 

  25. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006;296:1507–17.

    Article  CAS  PubMed  Google Scholar 

  26. Koornstra J-J, Vasen H-F-A. Surveillance colonoscopy practice in Lynch syndrome in the Netherlands: a nationwide survey. World J Gastroenterol WJG. 2007;13:4658–9.

    Article  PubMed  Google Scholar 

  27. Hurlstone DP, Karajeh M, Cross SS, McAlindon ME, Brown S, Hunter MD, et al. The role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening: a prospective “back-to-back” endoscopic study. Am J Gastroenterol. 2005;100:2167–73.

    Article  PubMed  Google Scholar 

  28. Lecomte T, Cellier C, Meatchi T, Barbier JP, Cugnenc PH, Jian R, et al. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol. 2005;3:897–902.

    Article  PubMed  Google Scholar 

  29. Hüneburg R, Lammert F, Rabe C, Rahner N, Kahl P, Büttner R, et al. Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy. 2009;41:316–22.

    Article  PubMed  Google Scholar 

  30. Rex DK. Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol. 2006;101:2866–77.

    Article  PubMed  Google Scholar 

  31. Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK, et al. Missed adenomas during colonoscopic surveillance in individuals with Lynch syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila). 2008;1:470–5.

    Article  Google Scholar 

  32. Rahmi G, Lecomte T, Malka D, Maniere T, Le Rhun M, Guimbaud R, et al. Impact of chromoscopy on adenoma detection in patients with Lynch syndrome: a prospective, multicenter, blinded, tandem colonoscopy study. Am J Gastroenterol. 2015;110:288–98. Prospective, controlled, multicenter study. Chromocolonoscopy with indigo carmine doubled both the total number of adenomas detected compared with standard colonoscopy alone.

    Article  PubMed  Google Scholar 

  33. East JE, Suzuki N, Stavrinidis M, Guenther T, Thomas HJW, Saunders BP. Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer. Gut. 2008;57:65–70.

    Article  CAS  PubMed  Google Scholar 

  34. Ramsoekh D, Haringsma J, Poley JW, van Putten P, van Dekken H, Steyerberg EW, et al. A back-to-back comparison of white light video endoscopy with autofluorescence endoscopy for adenoma detection in high-risk subjects. Gut. 2010;59:785–93.

    Article  PubMed  Google Scholar 

  35. van den Broek FJC, Fockens P, Van Eeden S, Kara MA, Hardwick JCH, Reitsma JB, et al. Clinical evaluation of endoscopic trimodal imaging for the detection and differentiation of colonic polyps. Clin Gastroenterol Hepatol. 2009;7:288–95.

    Article  PubMed  Google Scholar 

  36. Lai EJ, Calderwood AH, Doros G, Fix OK, Jacobson BC. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009;69:620–5.

    Article  PubMed  PubMed Central  Google Scholar 

  37. van Vugt van Pinxteren MWJ, van Kouwen MCA, van Oijen MGH, van Achterberg T, Nagengast FM. A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial. Fam Cancer. 2012;11:337–41.

    Article  Google Scholar 

  38. Stoffel EM, Mercado RC, Kohlmann W, Ford B, Grover S, Conrad P, et al. Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol. 2010;105:1851–60.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Hadley DW, Ashida S, Jenkins JF, Calzone KA, Kirsch IR, Koehly LM. Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation. Clin Genet. 2011;79:321–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Hill AL, Sumra KK, Russell MM, Yoo J, Ko CY, Hart S, et al. A single institution experience in compliance with universal screening for Lynch syndrome in colorectal cancer. J Gastrointest Surg. 2015;19:543–50.

    Article  PubMed  Google Scholar 

  41. de Jong AE, Hendriks YMC, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology. 2006;130:665–71.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hepatogastroenterology and Digestive Oncology, Trousseau University Hospital, CHRU de Tours 2 avenue de la République 37044, TOURS, Cedex 09, France

    Sandrine Féau, Morgane Caulet & Thierry Lecomte

  2. Université François Rabelais, Tours, France

    Morgane Caulet & Thierry Lecomte

Authors
  1. Sandrine Féau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Morgane Caulet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thierry Lecomte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandrine Féau.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Prevention and Early Detection

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Féau, S., Caulet, M. & Lecomte, T. What is the Best Colonoscopy Surveillance for Lynch Syndrome Patients?. Curr Colorectal Cancer Rep 12, 88–93 (2016). https://doi.org/10.1007/s11888-016-0314-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-016-0314-9

Keywords

Search

Navigation